Tenderwize
Back to tender search

Open house drug rebate agreements Lanthanum(III)-carbonate, ATC V03AE03

AOK Bayern - Die Gesundheitskasse·München, Germany·Deadline May 03, 2028 · 625 days left·Open·Supplies·Framework
Structured notice only
Original notice title

Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge Lanthan(III)-carbonat, ATC V03AE03

40/100

Opportunity Score

Needs reviewLow complexity
SuppliesFrameworkOpen
Why this score?

Opportunity

40 / 100

Complexity

20 / 100

Risk factors

No estimated value or guaranteed volume; revenue depends on actual usage and discount rates

Automatic termination if a competing nationwide or state-level rebate contract is concluded for the same active substan...

Deep Portfolio Analysis

Deep Company Fit Analysis

Uses:

  • Description
  • Industries & Services
  • Capabilities
  • Market & Experience
  • Certifications

Overview

Moderate opportunity

Key Facts

  • Framework procurement
  • Supplies contract
  • 1 lot
  • Duration until Jun 2028
  • Non-exclusive pharmaceutical rebate agreements for Lanthanum(III)-carbonate (ATC V03AE03)
  • Supply of pharmaceutical products to AOK Bayern at discounted prices
Show full summary

Non-exclusive open-house model for pharmaceutical rebate agreements on Lanthanum(III) carbonate (ATC V03AE03) with AOK Bayern. Eligible pharmaceutical companies can join at any time until 03 May 2028, with contracts running from 01 July 2026 to 30 June 2028. No estimated value provided. Submission is either in writing (two copies) or electronically with qualified electronic signature. Only self-declaration of reliability is required for eligibility. The contract is non-negotiable and non-exclusive.

Risks

No estimated value or guaranteed volume; revenue depends on actual usage and discount rates

Automatic termination if a competing nationwide or state-level rebate contract is concluded for the same active substan...

Analysis may be incomplete

Only part of the procurement documentation was analyzed. Additional eligibility requirements, certificates, or submission documents may exist in the remaining tender documentation.

Key Requirements

Eligibility

  • Only pharmaceutical companies are eligible

Administrative

  • Submission of signed self-declaration of reliability
  • Submission of signed contract and annex 'Festlegung der vertragsgegenständlichen Arzneimittel'

Requirements may be incomplete.

Award Criteria

Lot 1

No award criteria – all eligible companies are accepted.

Buyer

Location

München, DEU

Website

www.aok.de

Buyer profile

Open profile

Identifier

DE811695320

Activity

Health

Lots (1)

LOT-0001

Open house drug rebate agreements Lanthanum(III)-carbonate, ATC V03AE03

Open-house model for non-exclusive rebate agreements on pharmaceutical products containing Lanthanum(III)-carbonate (ATC V03AE03). Contracts available to all interested pharmaceutical companies meeting eligibility criteria. No selection process; all eligible companies can join. Duration from 01 July 2026 to 30 June 2028. Submission deadlines for joining: 3rd of each month for next month start, or later. Contracts may be terminated with one month's notice.

SuppliesFrameworkEU fundedElectronic submission

Location

DE212, Germany

Duration

Jun 2026 - Jun 2028

Category

Pharmaceutical products

Award Criteria

No award criteria – all eligible companies are accepted.

Deadline

Deadline May 03, 2028

Procurement Details

Publication date
17 May 2026
Languages
German

Reference metadata

Legal basis
32014L0024

Reference IDs

Tender ID
337536-2026

Documents (2)

Similar tenders